- £101.81m
- £149.67m
- £244.39m
- 83
- 76
- 87
- 96
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 209 | 200 | 188 | 219 | 244 |
Cost of Revenue | |||||
Gross Profit | 62.6 | 55.1 | 49.9 | 58.4 | 61.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 192 | 196 | 179 | 207 | 244 |
Operating Profit | 17.1 | 4.08 | 8.76 | 11.6 | -0.008 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 16.4 | 3.04 | 7.78 | 10.6 | -2.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.2 | -0.238 | 5.79 | 8.98 | -2.87 |
Net Income Before Extraordinary Items | |||||
Net Income | 12.2 | -0.238 | 5.79 | 8.98 | -2.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.2 | -0.238 | 5.79 | 8.98 | -2.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.099 | 0.039 | 0.047 | 0.069 | 0.02 |
Dividends per Share |